ISPE

MAY 9, 2023

In an era when the world is accelerating the development of drugs and targeted medicines using innovative technologies, pharmaceutical companies still face registration hurdles for well-characterized molecules because of redundant or additional local regulatory requirements.

Documentation 52

Documentation Packaging Pharmaceutical Companies Pharmaceutical Companies 52

Impact Pharmaceutical Services

SEPTEMBER 20, 2023

If commercial, accessibility of cGMP API for proof of concept (POC) studies is much more possible in bulk in the open market, and may already be packaged in a suitable dosage form or strength for human trials. The post Unlocking the Potential: The Power of Drug Repurposing in Modern Medicine appeared first on SYNER-G.

Documentation 59

Documentation Packaging Dosage Pharmaceutical Companies 59

Pharmaceutical Technology

SEPTEMBER 8, 2022

Find the leading pharmaceutical solid dose manufacturing companies in contract marketing. Pharmaceutical Technology has listed the top solid dose manufacturing companies and solid dose pharmaceutical companies based on our intel, insights and decades-long expertise in the sector.

Dosage 40

Dosage Packaging Documentation Pharmaceutical Companies 40

ISPE

MARCH 7, 2023

As such there’s a growing question of how the industry will improve the sustainability profile of its existing medicines and ensure that sustainability is designed into new medicines, such as products, with a reduced environmental risk, greener manufacturing technologies, and recyclable delivery systems and packaging. 9 December 2021.

Packaging 52

Packaging Pharmaceutical Companies Pharmaceutical Companies Hospitals 52

The Checkup by Singlecare

APRIL 5, 2024

Pharmaceutical companies typically only provide prescription drug samples to healthcare providers, who keep them in the office for patients to use. Samples often come in a package of four 2.5 Keep in mind that a healthcare provider will only give you free samples if they think it would benefit your specific condition.

Insurance 59

Insurance Compounding Pharmacies Compounding Insurance Coverage 59

European Pharmaceutical Review

JANUARY 25, 2024

These standardised documents provide meticulously curated and scientifically approved information. The responsibility of printing paper leaflets is currently a key regulatory obligation for pharmaceutical companies. They detail the medication’s intended use, proper administration, potential side effects and precautions.

Packaging 85

Packaging Documentation Pharmaceutical Companies Pharmaceutical Companies 85

pharmaphorum

OCTOBER 27, 2022

The Guidance applies to all member companies of EFPIA and IFPMA, but also acts as useful guidance for all pharmaceutical companies as to how the authorities will interpret the legislative provisions to social media channels. Therefore, companies are encouraged to establish a methodology for calculating fair market value rates.

Communication 96

Communication Packaging Documentation Pharmaceutical Companies 96

The People's Pharmacy

MAY 8, 2023

The same was true of another of the company’s products, Delsam Pharma Artificial Eye Ointment , which the company voluntarily recalled shortly after. “The FDA said Global Pharma failed to use adequate, tamper-evident packaging and distributed the drugs without proper preservatives.”

FDA 72

FDA Pharmaceutical Companies Pharmaceutical Companies Medical Schools 72

Viseven

SEPTEMBER 14, 2023

For example, a pharmaceutical brand can face increased acquisition costs if a supplier has not delivered on time. It also bears extra replacement expenses when drugs are discarded due to improper packaging. Technologies allow pharmaceutical companies to collect and analyze a massive amount of data to ensure proper drug safety.

Packaging 52

Packaging Pharmaceutical Companies Pharmaceutical Companies Pharmacy Procurement 52

ISPE

MARCH 7, 2023

A collaborative mindset must prevail between pharmaceutical companies, suppliers, and regulators and include strategic partnerships that go beyond the pharmaceutical sector so we can move together to a more sustainable future. The risks are equally applicable to both privately owned and publicly traded companies.

Health and Personal Care Stores 52

Health and Personal Care Stores Pharmaceutical Companies Pharmaceutical Companies Communication 52

ISPE

SEPTEMBER 10, 2023

In these countries, a secondary packaging site change or an active pharmaceutical ingredient (API) manufacturing site addition triggers a new submission equivalent to that required for approval of a generic drug or a line extension, whereas these site changes may be filed as a notification in the US and EU. Published March 2020.

Documentation 98

Documentation Process Improvement Packaging Pharmaceutical Companies 98

ISPE

JULY 6, 2023

9 As such, major investment is warranted for pharmaceutical companies to fully capitalize on the benefits of CM, and they need to make the hard business choice of investing time and money—with added risk—to widen their manufacturing portfolio versus putting money in established technologies that have been profitable.

HIV Treatment and Prevention Agents 52

HIV Treatment and Prevention Agents Dosage Pharmaceutical Companies Pharmaceutical Companies 52

Pharmaceutical Technology

SEPTEMBER 23, 2022

generic drugs at both small development companies and multinational pharmaceutical companies. This unique pedigree gives the company a foundational understanding of how to launch products at every stage of development.

Packaging 59

Packaging Controlled Substances FDA Documentation 59

pharmaphorum

AUGUST 16, 2021

Thankfully, paper-based studies are becoming a thing of the past, but spreadsheets and Word documents are still commonly used to design and build trials. These are now used by several regulatory bodies, including the Food and Drug Administration (FDA) and the Japanese Pharmaceuticals and Medical Devices Agency (PMDA) for submission packages.

Documentation 98

Documentation Vaccines Packaging Pharmaceutical Companies 98

European Pharmaceutical Review

FEBRUARY 2, 2023

This left pharmaceutical companies in Europe with no European API supply source, and only a few suppliers in Asia. The recent update to the EC Urban Waste Directive, part of the environment package ‘Towards Zero Pollution,’ 4 has a disproportionate producer responsibility principle that will incur considerable extra costs.

Generic Medicine 102

Generic Medicine Packaging Documentation Pharmaceutical Companies 102